Toronto (June 6, 2016) — Borden Ladner Gervais (BLG) is pleased to release the third edition of its report, Life Sciences Legal Trends in Canada. The report offers observations and analysis from BLG professionals, as well as comments from Canada’s national and regional life sciences associations.

BLG’s report includes articles discussing new Canadian IP enforcement guidelines, new Canadian examination guidelines for medical diagnostic methods, selected pharma and biotech implications of CETA-TPP, genetic discrimination, cyber risk management, outsourcing and procurement, and public capital markets developments.

“The biotechnology sector is rapidly evolving. This report shares insights on some of the more significant legal challenges faced by sector stakeholders,” said Jeffrey Graham, national leader of BLG’s Life Sciences Group. “BLG’s life sciences team looks forward to discussing these topics and more with industry representatives at the 2016 BIO International Convention in San Francisco.”

BLG’s life sciences practice extends from bench top to boardroom, providing strategic advice to clients across the spectrum of the sector. The firm’s multi-disciplinary life science group advises entrepreneurs and investors involved in the commercialization of life sciences technologies, as well as domestic and international clients with products in sale, including drugs, medical devices, natural health products, biomaterials, ag-biotech products and well as companies with energy/environmental applications.

About Borden Ladner Gervais LLP

Borden Ladner Gervais LLP (BLG) is a leading, national, full-service Canadian law firm focusing on business law, commercial litigation and arbitration, and intellectual property solutions for our clients. BLG is one of the country’s largest law firms with more than 725 lawyers, intellectual property agents and other professionals in five cities across Canada. We assist clients with their legal needs, from major litigation to financing to trademark and patent registration.

— 30 —

For more information or to arrange an interview, please contact: 

Stéphanie Alison Berthiaume
Borden Ladner Gervais LLP

Tia Thomas
Environics Communications Inc.

Alida Alepian
Capital Image
514.739.1188 ext.239